Resources
2 Results (showing 1 - 2)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 5/5/2020 (updated 3/28/2024)
This was the first session in the telehealth series. There were various speakers and panelists from agencies including JBS International, Global Partnership for Telehealth, H.O.P.E. Telehealth Consortium, HRSA’s Office for the Advancement of Telehealth, and the Telehealth Resource Centers.
Posted 8/18/2023 (updated 3/26/2024)
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) held an event where health care professionals and federal partners discussed xylazine-related testing, treatment, and wound care. As the White House has deemed fentanyl adulterated with xylazine an emerging threat, it is important to identify and adapt to the rapidly changing practices of patient care.